| {"0": "Degradation pathway of sphingolipids including diseases", "1": "Glycosaminoglycan degradation", "2": "Ebola virus infection in host", "3": "Complement system", "4": "Primary focal segmental glomerulosclerosis fsgs", "5": "Cholesterol metabolism with bloch and kandutschrussell pathways", "6": "Ferroptosis", "7": "Alzheimers disease and mirna effects", "8": "Base excision repair", "9": "Nuclear receptors metapathway", "10": "Embryonic stem cell pluripotency pathways", "11": "Alzheimers disease", "12": "Mapk cascade", "13": "Cytoplasmic ribosomal proteins", "14": "Splicing factor nova regulated synaptic proteins", "15": "Il7 signaling pathway", "16": "Metapathway biotransformation phase i and ii", "17": "Il9 signaling pathway", "18": "Nrf2 pathway", "19": "Pdgfrbeta pathway", "20": "Malignant pleural mesothelioma", "21": "Il3 signaling pathway", "22": "Fgfr3 signaling in chondrocyte proliferation and terminal differentiation", "23": "Hippomerlin signaling dysregulation", "24": "Adipogenesis", "25": "Il2 signaling pathway", "26": "Cysteine and methionine catabolism", "27": "Glycogen synthesis and degradation", "28": "Transsulfuration pathway", "29": "Myometrial relaxation and contraction pathways", "30": "Onecarbon metabolism and related pathways", "31": "Burn wound healing", "32": "Common pathways underlying drug addiction", "33": "Aryl hydrocarbon receptor pathway wp2586", "34": "Resistin as a regulator of inflammation"} |